Health
FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer – News-Medical.Net
The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss…
Reviewed by Emily Henderson, B.Sc.Nov 23 2020
The U.S. Food and Drug Administration has request for emergency use authorization a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH.
The FDA recognizes that transparency and dialogue are critical for the public to have confidence in COVID-19 vaccines. I want…
-
Noosa News24 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News22 hours agoFranz Ferdinand: Australian Tour 2025
-
General23 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win
-
Business22 hours agoHow these 5 ASX 200 stocks are smashing the benchmark this week